Definitive Contract 75D30120C09570
Award Date
9/22/20
Potential Completion Date
9/20/22
Potential Value
$847K
Federal Agency
CDC Pittsburgh
Awardee
Yale Univ
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Hamden, CT 06511, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $414,315 firm fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to Yale University, a private research university, to assess the contamination and survivability of SARS-CoV-2 on surfaces. The contract, which has a period of performance through September 27, 2022, was awarded on September 28, 2020 and is designated as related to the Coronavirus COVID-19 national interest action. No set-aside was used for this award. Yale University is registered in the...
<p>This is a $546,085 firm fixed-price definitive contract awarded on September 1, 2020 by the Centers for Disease Control and Prevention (CDC), a civilian agency, to Yale University, a private university, for the identification of epidemiologic and microbiome-related risk factors. The contract has an ultimate completion date of February 28, 2022. This contract does not have a set-aside designation. The place of performance is Hamden, CT.</p>
This is a Firm Fixed Price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Yale University to conduct SARS-CoV-2 sero-surveillance in indigenous casino workers. The contract has a ceiling value of $699,595.00 and a period of performance through April 30, 2022. There was no set-aside used for this award. As a private research university, Yale University has a history of providing research, analysis, and testing services to various federal agencies through...
This is a $459,721 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Yale University, a private research university, to conduct research on "Microbiome Disruption Indices." The contract has no set-aside designation. As a subcontractor, the University of Maryland, Baltimore (UMB) is providing frozen patient samples and clinical data to support the research effort. This contract award is part of Yale University's broader portfolio of federal prime...
This is a cost-no-fee definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Johns Hopkins University, a private research university, to provide COVID-19 response efforts. The $1,835,654.79 contract has a performance period running from July 1, 2020 through June 30, 2023. As part of this contract, Vanderbilt University Medical Center (VUMC) is serving as a subcontractor to provide molecular testing and epidemiology support, including day-to-day supervision...
This is a definitive, firm fixed price contract awarded to Yale University by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The contract, valued at $1,980,573.00, is for the FY22 Broad Agency Announcement (BAA) YALE, with a period of performance through March 18, 2025. The contract is not set-aside. As a private university, Yale University is registered in the System for Award Management (SAM) and provides a range of services including education and research. Through this...
The University of Georgia Research Foundation, Inc. was awarded a firm fixed price, definite contract valued at one million, one hundred sixteen thousand, five hundred thirty-nine dollars ($1,116,539) by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh. The contract is for SARS-COV-2 applied research with a period of performance through January 31, 2023 and no set aside designation was used. Major subcontracting support is being provided by the...
This is a definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, to The Johns Hopkins University. The contract, valued at $87,568,834.00, will support NIAID's Centers of Excellence for Influenza Research and Response (CEIRR) program. The contract does not utilize any set-aside designation. Under this contract, The Johns Hopkins University will provide a range of research,...
This is a federal contract award to The Johns Hopkins University, a private non-profit research university, for a Delivery Order under the Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) Indefinite Delivery Vehicle. The contract, valued at $4,999,612.00, is for modeling and implementation services related to 2021 Domain 1-A013 for the Centers for Disease Control and Prevention (CDC). The contract has a period of performance through February 12, 2025 and...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $49,995,944 definitive cost-no-fee contract to Vanderbilt University Medical Center for Surveillance of Acutely Ill Adults with Respiratory Viruses, Including SARS-CoV-2. Vanderbilt University Medical Center will serve as the prime contractor and has subcontracted portions of the work to 26 other institutions, including The Cleveland Clinic Foundation, University of Utah, Beth Israel Deaconess...